Start6 · Institutional review & transfer6.1 · Review process & due diligence
Content status: 24 August 2026Website 2.2.2
STRATEGIC REVIEW PROCESS

Understand first, then review – and disclose sensitive core substance only when the review purpose actually requires it.

A professional process should achieve two things at the same time: give the prospective institution enough substance to prepare a robust decision while avoiding unnecessary early disclosure of proprietary core logic. Information depth therefore increases with the seriousness and precision of the review question.

no blanket data-room releaseobjective review questionscore IP at the end of the chain
SIX STAGES

From first orientation to a potential strategic decision

The stages are not a rigid contractual model. They describe a sensible order for reviewing relevance, evidence, rights and sensitive substance.

With each stage, the following increase:Information depth ↑Confidentiality / IP sensitivity ↑
0
PUBLIC

Orientation

Website, Executive Overview, Evidence & Validation Brief, Evidence Map, project status, methodology and publication history.

Decision question:

Is the substance relevant enough to justify a qualified discussion?

1
QUALIFICATION

Strategic fit

Use case, institution type, technical environment, review priorities and the potential role of the Framework are defined more precisely.

Decision question:

Which layer should actually be reviewed, and for what purpose?

2
CONFIDENTIALITY

NDA & targeted deepening

For serious interest, selected confidential materials can be released without opening the entire core IP.

Decision question:

Does the documented state justify technical or methodological review?

3
TECHNICAL REVIEW

Reproducibility & architecture

The whitepaper, selected test definitions, architecture, known limitations and – once completed – replication and validation reports are reviewed against specific questions. Once the operating validation layer exists, clearly versioned live-execution and risk reports may be added as a separate evidence source.

Decision question:

Can the relevant substance be understood, reproduced and mapped into the target environment?

4
DUE DILIGENCE

Rights, data, code, security & handover

The questions that performance charts cannot answer are reviewed: IP chain, data rights, third-party components, security, documentation, open risks and transferability.

Decision question:

Is the asset legally, technically and organisationally defined well enough to structure a transaction or partnership?

5
STRATEGIC DECISION

Partnership, investment, acquisition or option

Only at this stage are structure, rights, scope, handover, founder involvement, potential exclusivity and economic terms negotiated in detail.

Decision question:

Which structure appropriately reflects demonstrated value and remaining risk?

INFORMATION BY REVIEW STAGE

More material only where it answers a specific question.

A data room should not become a completeness theatre. Each released document should have a clear review purpose, and its evidence status should remain visible.

Typical material and decision purpose by review stage
StageTypical materialDecision supported
PublicWebsite, Executive Overview, Evidence Brief, Fact SheetBasic understanding and strategic relevance
QualifiedProject status, targeted Q&A, selected methodologyReview focus and potential use case
Under NDAconfidential whitepaper, selected architecture and source-state materialSubstance, limitations and technical fit
Technical reviewreproducible test definitions and - once completed - replication, intraday, cost and APS reports; later, where applicable, versioned live-execution reportsEvidence quality and technical viability
Due diligencedata/IP rights, code/dependency review, security, documentation, handover packageTransferability, risks and transaction readiness
Transactiondefined IP scope, rights, handover, involvement, warranties and boundariesContractual and economic structure
NO DATA-ROOM THEATRE

A file does not become evidence merely because it sits in a folder called “Due Diligence”.

A replication report exists only after replication has been performed. An intraday report exists only after event ordering has been tested on appropriate data. A security review is complete only once it has actually taken place.

The review process therefore separates existing source material from future Version 2 reports. A reviewer should always be able to distinguish a historical finding, current evidence, an open review item and a development objective.

Document rule

A new data or calculation state does not silently overwrite an older finding. Material changes create a new version, and significant deviations are documented. Editorial approval does not replace a passed validation gate.

STRATEGIC OBJECTIVE & POSSIBLE STRUCTURES

The preferred target is a fully transferable operating unit - without pre-negotiating economic terms publicly.

The long-term target state is designed so that complete acquisition of the built company can be considered where strategic fit exists. Partnership or minority structures may still be useful during development. Purchase price, valuation, ownership percentage, exclusivity and timing are deliberately not fixed publicly.

01

Strategic development partnership

Joint industrialisation or validation with clearly defined rights, responsibilities and disclosure levels.

02

Minority or development investment

Capital and strategic support may fund the next development stage without automatically pre-determining a later acquisition.

03

Complete acquisition or option structure

Where strategic fit is high, complete acquisition of the built operating unit is the preferred long-term target. A staged option may be appropriate where maturity and evidence do not yet support a direct acquisition.

No economic pre-commitment: this website does not promise an ownership percentage, valuation, purchase price, exclusivity or binding exit date. If no suitable transaction emerges, the operating unit can continue to be used and monetised through other routes; that alternative provides economic optionality but is not an equal-priority first-phase development programme. See strategic classification →
TRANSACTION READINESS

What a professional acquisition process eventually has to clarify

Even an excellent backtest is not a transferable asset if ownership, rights, dependencies and handover are unclear. The following issues therefore belong in later due diligence.

01

IP perimeter

Which rules, documents, data models, software components, marks and know-how areas are actually part of the transaction?

02

Data & third-party rights

Which data may be transferred, reproduced or used in production? Which libraries, licences or services remain third-party components?

03

Technical state

Which components are reference prototypes, which are replicated, which are production-oriented and which remain development objectives?

04

Evidence state

Which statements are documented, independently reproduced, tested on new data or still open?

05

Handover

Which documentation, installation and operating material, test cases and knowledge-transfer steps are required so the core can continue without permanent founder dependency?

06

Boundaries & liability

Which known limitations, open work, warranty issues and regulatory responsibilities need to be contractually separated?

QUALIFIED DISCUSSION

The most useful first step is a clearly formulated review question.

Which institution, which potential use case and which two or three points should be reviewed first? That information allows the discussion to begin at the appropriate documentation and confidentiality level.